A study reported that IDO1 blockage could overcome radiation-induced “Rebound Immune Suppression” in the tumor microenvironment and sensitized Lewis lung carcinoma (LLC) tumors to hypo-fractionated RT [30]. This evidence concerns the gene IDO1 and neoplasm.